Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 368

recruiting
3 987
countries
28
conditions
2 109

4 491 trials match your criteria

Study on Nemvaleukin Alfa and Pembrolizumab for Patients with Advanced Skin or Mucosal Melanoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nemvaleukin Alfa
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab

Transplant rejection

Not recruiting

Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa

Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib

Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan

Study of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab

Dermatitis atopic

Not recruiting

Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Nemolizumab

Endometrial cancer+2

Not recruiting

Study on Selinexor as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Selinexor

Ischaemic stroke

Not recruiting

Study on the Safety of Afamelanotide for Patients with Acute Arterial Ischemic Stroke Ineligible for Standard Stroke Treatments

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Afamelanotide

Renal cell carcinoma

Not recruiting

Study Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab

Pulmonary embolism

Not recruiting

Study on Pulmonary Embolism: Comparing Iomeprol Dosages in CT Scans for Patients with Suspected Pulmonary Embolism

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Iomeprol

Dry eye

Not recruiting

Study on Insulin Eye Drops for Treating Dry Eye in Patients Using Topical Hypotensors

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Hypromellose
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.